BioCatalyst

BI 690517, Empagliflozin — catalyst calendar

1 verified catalyst event(s) referencing BI 690517, Empagliflozin, each linked to its official source. Verified as of 2026-09-23.

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-12-31
in 3mo
ESTIMATED
 READOUT
EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combina
Phase 3 · Kidney Disease, Chronic
 Boehringer Ingelheim BI 690517, Empagliflozin ClinicalTrials.gov ↗
✓ Source-checked 2026-09-23
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.